86. Expert Opin Drug Discov. 2018 Aug;13(8):685-690. doi:10.1080/17460441.2018.1479740. Epub 2018 May 24.Challenges with biomarkers in cancer drug discovery and development.Ileana Dumbrava E(1), Meric-Bernstam F(1)(2)(3), Yap TA(1)(2)(4)(5).Author information: (1)a Department of Investigational Cancer Therapeutics (Phase I Program) , TheUniversity of Texas MD Anderson Cancer Center , Houston , Texas , USA.(2)b Khalifa Institute for Personalized Cancer Therapy , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.(3)c Department of Breast Surgical Oncology , The University of Texas MD AndersonCancer Center , Houston , Texas , USA.(4)d Institute for Applied Cancer Science , The University of Texas MD AndersonCancer Center , Houston , Texas , USA.(5)e Department of Thoracic/Head and Neck Medical Oncology.DOI: 10.1080/17460441.2018.1479740 PMID: 29792354 